Editor’s note: CopperMask backs up its claims through test results from four reputable institutions. Below is their press release.

By seriously taking on the challenge of ensuring the health and safety of Filipinos during the pandemic, CopperMask – a brand known for its stylish and unique face masks that are infused with copper strands – underwent tests and has now been clinically proven to have the potential to deactivate and kill the world’s biggest enemy to date, the coronavirus.

The all-new CopperMask copper strand-infused face masks, which were proven earlier to have the capacity to block and kill common bacteria and viruses, have also been confirmed to have the ability to deactivate and potentially kill the coronavirus by up to 99% in just 2 hours.*

In a test conducted by Shanghai WEIPU Chemical Technology Service Co., Ltd., an ILAC-MRA/CNAS certified research-based testing laboratory facility in Shanghai, China (certified in accordance to ISO/IEC standards), the CopperMask antimicrobial film was subjected to an antiviral assay test to determine if it has the potential ability or capacity to kill the coronavirus. The type of virus used in this test was GX-P2V (Guanxu pangolin coronavirus), a coronavirus that falls into the same lineage as the SARS-CoV-2 obtained from pangolins. It is believed that SARS-CoV-2 might be of “probable pangolin origin.”

The GX-P2V coronavirus has more than 90% similarity in terms of genome sequence and 92.2% structural resemblance to the SARS-CoV-2, more commonly known as COVID-19.

Was CopperMask tested against COVID-19? If not, why?

SARS-CoV-2 or COVID-19, the root cause of the pandemic, is a highly contagious disease. For this reason and other safety purposes, many testing facilities that develop therapeutics, disinfectants, and even vaccines have widely accepted the use of GX-P2V as an ideal substitute due to its high degree of affinity (amino acid sequence, ace receptor, and the like).

What the test has proven:

CopperMask’s antimicrobial film was proven to have the capacity to weaken the activity rate of the coronavirus by up to 99.07% after an incubation period of 2 hours, and 99.15% after 24 hours, thus, deactivating and potentially killing the coronavirus.

CopperMask also underwent extensive clinical tests from reputable research testing facilities in China and South Korea to test its efficacy and safety against common bacteria and viruses, and to verify if there are harmful chemicals and heavy metals present.

Here are the certified test results:

• CopperMask blocks 99.99% of common bacteria and viruses**
• CopperMask kills 99.99% of bacteria***
• CopperMask contains no harmful chemicals and heavy metals****

Given all these tests, is CopperMask a medical-grade face mask?

According to WHO, medical-grade face masks should have the following characteristics:

• Has 3 layers of synthetic nonwoven materials
• Configured to have filtration layers sandwiched in the middle
• Available in different thicknesses
• Has various levels of fluid resistance and filtration

So CopperMask is not to be used in medical facilities and hospitals where appropriate medical face masks are required.

Without a doubt, the COVID-19 outbreak has tremendously changed the way people lived. After the lockdown, people searched for ways to survive and protect themselves from the virus while adapting to the new normal. Wearing face masks is one of them.

CopperMask is a lifestyle face mask. In a situation where people need to wear it and make it an indispensable part of their everyday life, CopperMask seals the deal by making this protective gear more stylish and aesthetically pleasing while ensuring that everyone is safe while doing errands and outdoor activities. And these do not include medical facilities and hospitals where appropriate medical face masks are required.

Learn more about CopperMasks through www.coppermask.ph. – Rappler.com

REFERENCES:

*Report No: WP-21055252-JC-01En, Shanghai WEIPU Chemical Technology Service Co., Ltd.

**Report No: 2021FM09775R01E, GMICRO TESTING Guangdong Detection Center of Microbiology, China

***Report No: F232-20-15510, FITI, Korea

****Report No: F690101/LF-CTSAYAA20-62390, SGS, Korea

WHO

Nature